Correction to: Cardiovascular risk of gonadotropin-releasing hormone antagonist versus agonist in men with prostate cancer: an observational study in Taiwan

Mostrar otras versiones (1)
Detalles Bibliográficos
Autores principales: Shao, Yu-Hsuan Joni, Hong, Jian-Hua, Chen, Chun-Kai, Huang, Chao-Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10449617/
https://www.ncbi.nlm.nih.gov/pubmed/35821250
http://dx.doi.org/10.1038/s41391-022-00568-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10449617/
https://www.ncbi.nlm.nih.gov/pubmed/35821250
http://dx.doi.org/10.1038/s41391-022-00568-9

Ejemplares similares